Fistuloclysis Improves Liver Function and Nutritional Status in Patients with High-Output Upper Enteric Fistula

Table 2

Demographics and clinical characteristics of the fistuloclysis subgroups.

Characteristics	Group 1 (𝑛=11)	Group 2 (𝑛=16)	Group 3 (𝑛=8)	𝑃 value
Age (years)	53.2±14.1	48.9±11.2	47.9±13.4	0.346
Male, 𝑛 (%)	7 (63.6)	11 (68.8)	5 (62.5)	0.680
BMI (kg/m^2)	20.1±3.5	19.5±2.6	18.8±4.2	0.362
Scores on admission
APACHE II (24 h)	11.0±3.1	12.2±2.7	11.1±3.5	0.072
SOFA (24 h)	4.4±1.2	4.9±1.1	4.4±1.3	0.060
Etiology, 𝑛 (%)
Trauma	4 (36.4)	7 (43.8)	3 (37.5)	0.916
Tumor	1 (9.1)	1 (6.3)	1 (12.5)	0.876
Ischemic enteropathy	1 (9.1)	0 (0)	0 (0)	0.304
Operations	2 (18.2)	6 (37.5)	2 (25.0)	0.527
Pancreatitis	2 (18.2)	2 (12.5)	1 (12.5)	0.904
IBD	1 (9.1)	0 (0)	1 (12.5)	0.272
Underlying disease, 𝑛 (%)
Cancer	1 (9.1)	3 (18.8)	2 (25.0)	0.629
Cardiovascular disease	1 (9.1)	1 (6.3)	0 (0)	0.563
Diabetes	1 (9.1)	2 (12.5)	1 (12.5)	0.956
COPD	2 (18.2)	2 (12.5)	1 (12.5)	0.908
None	7 (63.6)	8 (50.0)	4 (50.0)	0.752

Group 1: patients with jejunal-ileal fistula; Group 2: patients with biliary fistula; Group 3: patients with duodenal fistulas. BMI: body mass index; APACHE II: acute physiology score and chronic health evaluation II; SOFA: sequential organ failure assessment score; IBD: inflammatory bowel disease; COPD: chronic obstructive pulmonary disease. Data were presented as mean ± SD. 𝑃 value < 0.05 was deemed significant.